Profile for Denmark Patent: 1881823
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Denmark Patent: 1881823
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 8,084,047 | May 17, 2026 | Bausch And Lomb Inc | XIIDRA | lifitegrast |
| 8,168,655 | May 9, 2029 | Bausch And Lomb Inc | XIIDRA | lifitegrast |
| 8,592,450 | May 17, 2026 | Bausch And Lomb Inc | XIIDRA | lifitegrast |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
